Medication Error: A Case Report of Misadventure with Methotrexate
Methotrexate is an antimetabolite drug with antineoplastic and immunomodulatory properties, useful as an antineoplastic agent in various haematological and solid tumours. MTX toxicity can occur because of accidental ingestion/overdose by the patient or because of prescription error. The toxic effects manifest as severe mucositis or as organ damage (bone marrow depression, renal/hepatic injury). The toxicity usually results from parenteral overdose or repeated chronic drug ingestion. Acute high dose ingestion does not result in MTX toxicity because of saturable absorption kinetics. We present a case of MTX toxicity occurring as a result of prescription error resulting in repeat daily dosing of the drug, and the challenges associated with the management of the same, in a patient with multiple comorbidities. The present case emphasizes on a note of caution on the part of the prescriber and the suggestions regarding the measures which can be taken to avoid MTX toxicity.
2. LoVecchio F, Katz K, Watts D, Wood I. Four-year experience with methotrexate exposures. J Med Toxicol. 2008;4:149-50. [DOI: 10.1007%2FBF03161192]
3. Hensley MD, Bebarta VS, Borys DJ. A Large Case Series of Acute Pediatric Methotrexate Ingestions: Significant Clinical Effects Are Rare. Pediatr Emerg Care. 2016;32(10):682-4. [DOI: 10.1097/PEC.0000000000000785]
4. Hays H, Beuhler MC, Spiller HA et al. Evaluation of toxicity after acute accidental methotrexate ingestions in children under 6 years old: a 16-year multi-center review. Clin Toxicol (Phila). 2018;56(2):120-5. [DOI: 10.1080/15563650.2017.1349319.]
5. Bebarta VS, Hensley MD, Borys DJ. Acute methotrexate ingestions in adults: a report of serious clinical effects and treatments. J Toxicol. 2014;2014:214574. [DOI: 10.1155/2014/214574]
6. Chan ES, Cronstein BN. Methotrexate--how does it really work? Nat Rev Rheumatol. 2010;6(3):175–8. [DOI: 10.1038/nrrheum.2010.5]
7. Madke B, Singh AL. Acute methotrexate toxicity. Indian J Drugs Dermatol 2015;1:46-9. [DOI: 10.4103/WKMP-0110.170764]
8. Çaliskan E, Tunca M, Açikgöz G, Arca E, Akar A. Accidental high-dose methotrexate toxicity due to an electronic prescribing error. Indian journal of dermatol, venereal leprol. 2013;80(3):268–9. [DOI: 10.4103/0378-6323.132264.]
9. Chan BS, Dawson AH, Buckley NA. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning? Clin Toxicol (Phila). 2017;55(2):88–96. [DOI: 10.1080/15563650.2016.1271126]
10. Cheung KK, Chow KM, Szeto CC, Tai MH, Kwan BC, Li PK . Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate. J Clin Rheumatol. 2009;15(4):177–80. [DOI: 10.1097/RHU.0b013e3181a61f2d]
11. Izzedine H, Launay-Vacher V, Karie S, Caramella C, de Person F, Deray G. Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin Nephrol. 2005;64:315–9. [PMID: 16240905]
12. Pitman SW, Frei E 3rd. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin’s lymphoma. Cancer Treat Rep. 1977;61:695–701. [PMID: 18282]
13. Cohen IJ, Wolff JE. How Long Can Folinic Acid Rescue Be Delayed After High-Dose Methotrexate Without Toxicity? Pediatr Blood Cancer. 2014;61:7–10. [DOI :10.1002/pbc.24770]
14. Yoon KH, Ng SC. Early onset methotrexate‐induced pancytopenia and response to G-CSF: A report of two cases. J Clin Rheumatol. 2001;7:17-20. [PMID: 17039083]
15. Goldie JH, Price LA, Harrap KR. Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern. Eur J Cancer. 1972;8:409–14. [PMID: 5073303]
16. Cairns R, Brown JA, Lynch A, Robinson J, Wylie C, Buckley NA. A decade of Australian methotrexate dosing errors. Med J Aust. 2016;204:384. [PMID: 27256650]
Copyright (c) 2018 Anup Singh, Aru Chhabra Handa
This work is licensed under a Creative Commons Attribution 4.0 International License.
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.